Hustler Words – Billy Evans, partner of disgraced Theranos founder Elizabeth Holmes, is reportedly spearheading a new blood-testing startup, Haemanthus, according to a recent hustlerwords.com report citing The New York Times. This venture, aiming to raise over $50 million, employs laser technology to analyze blood, saliva, and urine samples for disease detection, focusing initially on pet health before targeting human applications. The ambitious plan bears a striking resemblance to Theranos’s ultimately fraudulent promises of revolutionary blood testing. The similarities have raised eyebrows, with at least one prominent investor, early Facebook investor Jim Breyer, reportedly rejecting an investment opportunity due to concerns mirroring those surrounding Theranos. The article highlights the inherent risks and ethical considerations associated with such ventures, especially given Holmes’s past convictions and ongoing imprisonment. The question remains: will Haemanthus overcome the shadow of its predecessor, or is this a case of history repeating itself?
Leave a Comment